Amy M. McCord
General Counsel at INHIBITOR THERAPEUTICS, INC.
Profile
Amy M.
McCord is currently the Vice President-Regulatory Affairs at Inhibitor Therapeutics, Inc. She previously worked as the Director-Regulatory Affairs at Davis Strategic Innovations, Inc. from 2016 to 2019, as the Senior Manager-Clinical Research at Accentia Biopharmaceuticals, Inc. from 2009 to 2015, and as a Scientist at OSO BioPharmaceuticals Manufacturing LLC from 2015 to 2016.
Prior to her career in industry, she earned a doctorate degree from USF Health Morsani College of Medicine in 2005.
Amy M. McCord active positions
Companies | Position | Start |
---|---|---|
INHIBITOR THERAPEUTICS, INC. | General Counsel | 2018-12-31 |
Former positions of Amy M. McCord
Companies | Position | End |
---|---|---|
Davis Strategic Innovations, Inc.
Davis Strategic Innovations, Inc. Engineering & ConstructionIndustrial Services Davis Strategic Innovations, Inc. provides systems, technology, and management solutions. Its services include aerospace and defense engineering, safety and environmental, strategic planning, information technology, bioterrorism, food defense, medical and public health services. The firm provides solutions to industries such as Aerospace, Defense, Medical, Environmental, and Homeland Security. Davis Strategic Innovations was founded in 2006 and is headquartered in Huntsville, AL. | General Counsel | 2018-12-31 |
OSO BioPharmaceuticals Manufacturing LLC
OSO BioPharmaceuticals Manufacturing LLC Pharmaceuticals: MajorHealth Technology OSO BioPharmaceuticals Manufacturing LLC delivers the sterile contract manufacturing and drug development services. It offers manufacturing of medical, surgical, ophthalmic, veterinary instruments and apparatus. The company was founded in May 2008 and is headquartered in Albuquerque, NM. | Corporate Officer/Principal | 2016-10-31 |
ACCENTIA BIOPHARMACEUTICALS INC | Corporate Officer/Principal | 2015-03-31 |
BioVest International, Inc.
BioVest International, Inc. Medical SpecialtiesHealth Technology BioVest International, Inc. develops and commercializes personalized therapeutic cancer vaccine for the treatment of B-cell blood cancers. The firm continued development, commercialization, manufacture and sale of AutovaxID and other instruments and disposables; and the commercial sale and production of cell culture products and services. The company was founded in 1981 and is headquartered in Tampa, FL. | Corporate Officer/Principal | - |
Training of Amy M. McCord
USF Health Morsani College of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
INHIBITOR THERAPEUTICS, INC. | Health Technology |
Private companies | 4 |
---|---|
BioVest International, Inc.
BioVest International, Inc. Medical SpecialtiesHealth Technology BioVest International, Inc. develops and commercializes personalized therapeutic cancer vaccine for the treatment of B-cell blood cancers. The firm continued development, commercialization, manufacture and sale of AutovaxID and other instruments and disposables; and the commercial sale and production of cell culture products and services. The company was founded in 1981 and is headquartered in Tampa, FL. | Health Technology |
Davis Strategic Innovations, Inc.
Davis Strategic Innovations, Inc. Engineering & ConstructionIndustrial Services Davis Strategic Innovations, Inc. provides systems, technology, and management solutions. Its services include aerospace and defense engineering, safety and environmental, strategic planning, information technology, bioterrorism, food defense, medical and public health services. The firm provides solutions to industries such as Aerospace, Defense, Medical, Environmental, and Homeland Security. Davis Strategic Innovations was founded in 2006 and is headquartered in Huntsville, AL. | Industrial Services |
OSO BioPharmaceuticals Manufacturing LLC
OSO BioPharmaceuticals Manufacturing LLC Pharmaceuticals: MajorHealth Technology OSO BioPharmaceuticals Manufacturing LLC delivers the sterile contract manufacturing and drug development services. It offers manufacturing of medical, surgical, ophthalmic, veterinary instruments and apparatus. The company was founded in May 2008 and is headquartered in Albuquerque, NM. | Health Technology |
Accentia Biopharmaceuticals, Inc.
Accentia Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Accentia Biopharmaceuticals, Inc. engages in the commercialization of patent-protected disruptive healthcare technologies. It offers products under the BiovaxID., Revimmune, and SinuNase brands. The company was founded in 2002 and is headquartered in Tampa, FL. | Health Technology |
- Stock Market
- Insiders
- Amy M. McCord